**Recent legislative action centered on the One Big Beautiful Bill Act (OBBBA), signed in July 2025, which permanently extended most 2017 TCJA business provisions—including full expensing, domestic R&D deductibility, and modified international rules—while preserving the 21% corporate rate.** No subsequent measures have advanced a further statutory rate reduction. With the November 2026 midterms approaching, congressional attention has shifted to appropriations, defense authorization, and other year-end priorities during the lame-duck period. Limited floor time and the absence of active reconciliation instructions targeting corporate rates constrain prospects for new rate legislation before 2027. Corporate receipts have declined due to OBBBA incentives, but this reflects existing policy rather than new rate cuts. Traders view the compressed timeline and crowded agenda as significant barriers to enactment.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · AtualizadoSim
9% chance
$16,849 Vol.
$16,849 Vol.
31 dez 2026
Sim
9% chance
$16,849 Vol.
$16,849 Vol.
31 dez 2026
This market will resolve to "Yes" if Donald J. Trump, as President of the United States, signs into law a bill that lowers the corporate tax rate in the United States below 21% at any point by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
Note that the cut does not need to go into effect before the resolution date - it just needs to be signed into law by then.
This market's primary resolution source will be official information from the Trump administration, however a consensus of credible information will also be used.
**Recent legislative action centered on the One Big Beautiful Bill Act (OBBBA), signed in July 2025, which permanently extended most 2017 TCJA business provisions—including full expensing, domestic R&D deductibility, and modified international rules—while preserving the 21% corporate rate.** No subsequent measures have advanced a further statutory rate reduction. With the November 2026 midterms approaching, congressional attention has shifted to appropriations, defense authorization, and other year-end priorities during the lame-duck period. Limited floor time and the absence of active reconciliation instructions targeting corporate rates constrain prospects for new rate legislation before 2027. Corporate receipts have declined due to OBBBA incentives, but this reflects existing policy rather than new rate cuts. Traders view the compressed timeline and crowded agenda as significant barriers to enactment.
This market will resolve to "Yes" if Donald J. Trump, as President of the United States, signs into law a bill that lowers the corporate tax rate in the United States below 21% at any point by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
Note that the cut does not need to go into effect before the resolution date - it just needs to be signed into law by then.
This market's primary resolution source will be official information from the Trump administration, however a consensus of credible information will also be used.
Note that the cut does not need to go into effect before the resolution date - it just needs to be signed into law by then.
This market's primary resolution source will be official information from the Trump administration, however a consensus of credible information will also be used.
Mercado Aberto: Nov 5, 2025, 1:03 PM ET
Volume
$16,849Data de Término
1 jan 2027Mercado Aberto
Nov 5, 2025, 1:03 PM ETResolver
0x65070BE91...This market will resolve to "Yes" if Donald J. Trump, as President of the United States, signs into law a bill that lowers the corporate tax rate in the United States below 21% at any point by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
Note that the cut does not need to go into effect before the resolution date - it just needs to be signed into law by then.
This market's primary resolution source will be official information from the Trump administration, however a consensus of credible information will also be used.
**Recent legislative action centered on the One Big Beautiful Bill Act (OBBBA), signed in July 2025, which permanently extended most 2017 TCJA business provisions—including full expensing, domestic R&D deductibility, and modified international rules—while preserving the 21% corporate rate.** No subsequent measures have advanced a further statutory rate reduction. With the November 2026 midterms approaching, congressional attention has shifted to appropriations, defense authorization, and other year-end priorities during the lame-duck period. Limited floor time and the absence of active reconciliation instructions targeting corporate rates constrain prospects for new rate legislation before 2027. Corporate receipts have declined due to OBBBA incentives, but this reflects existing policy rather than new rate cuts. Traders view the compressed timeline and crowded agenda as significant barriers to enactment.
This market will resolve to "Yes" if Donald J. Trump, as President of the United States, signs into law a bill that lowers the corporate tax rate in the United States below 21% at any point by December 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."
Note that the cut does not need to go into effect before the resolution date - it just needs to be signed into law by then.
This market's primary resolution source will be official information from the Trump administration, however a consensus of credible information will also be used.
Note that the cut does not need to go into effect before the resolution date - it just needs to be signed into law by then.
This market's primary resolution source will be official information from the Trump administration, however a consensus of credible information will also be used.
Volume
$16,849Data de Término
1 jan 2027Mercado Aberto
Nov 5, 2025, 1:03 PM ETResolver
0x65070BE91...**Recent legislative action centered on the One Big Beautiful Bill Act (OBBBA), signed in July 2025, which permanently extended most 2017 TCJA business provisions—including full expensing, domestic R&D deductibility, and modified international rules—while preserving the 21% corporate rate.** No subsequent measures have advanced a further statutory rate reduction. With the November 2026 midterms approaching, congressional attention has shifted to appropriations, defense authorization, and other year-end priorities during the lame-duck period. Limited floor time and the absence of active reconciliation instructions targeting corporate rates constrain prospects for new rate legislation before 2027. Corporate receipts have declined due to OBBBA incentives, but this reflects existing policy rather than new rate cuts. Traders view the compressed timeline and crowded agenda as significant barriers to enactment.
Resumo experimental gerado por IA com dados do Polymarket. Isto não é aconselhamento de trading e não tem qualquer papel na resolução deste mercado. · Atualizado
Cuidado com os links externos.
Cuidado com os links externos.
Frequently Asked Questions